1. Home
  2. TITN vs ALLO Comparison

TITN vs ALLO Comparison

Compare TITN & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TITN
  • ALLO
  • Stock Information
  • Founded
  • TITN 1980
  • ALLO 2017
  • Country
  • TITN United States
  • ALLO United States
  • Employees
  • TITN N/A
  • ALLO N/A
  • Industry
  • TITN Other Specialty Stores
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TITN Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • TITN Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • TITN 341.6M
  • ALLO 338.9M
  • IPO Year
  • TITN 2007
  • ALLO 2018
  • Fundamental
  • Price
  • TITN $17.07
  • ALLO $1.55
  • Analyst Decision
  • TITN Buy
  • ALLO Strong Buy
  • Analyst Count
  • TITN 5
  • ALLO 10
  • Target Price
  • TITN $19.00
  • ALLO $9.66
  • AVG Volume (30 Days)
  • TITN 275.6K
  • ALLO 2.6M
  • Earning Date
  • TITN 05-22-2025
  • ALLO 05-12-2025
  • Dividend Yield
  • TITN N/A
  • ALLO N/A
  • EPS Growth
  • TITN N/A
  • ALLO N/A
  • EPS
  • TITN N/A
  • ALLO N/A
  • Revenue
  • TITN $2,702,122,000.00
  • ALLO $22,000.00
  • Revenue This Year
  • TITN N/A
  • ALLO N/A
  • Revenue Next Year
  • TITN $3.22
  • ALLO $9.07
  • P/E Ratio
  • TITN N/A
  • ALLO N/A
  • Revenue Growth
  • TITN N/A
  • ALLO N/A
  • 52 Week Low
  • TITN $12.30
  • ALLO $1.23
  • 52 Week High
  • TITN $24.28
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • TITN 57.06
  • ALLO 49.84
  • Support Level
  • TITN $16.18
  • ALLO $1.38
  • Resistance Level
  • TITN $16.44
  • ALLO $1.75
  • Average True Range (ATR)
  • TITN 0.99
  • ALLO 0.13
  • MACD
  • TITN 0.14
  • ALLO 0.04
  • Stochastic Oscillator
  • TITN 99.69
  • ALLO 61.54

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: